BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• Antibe Therapeutics Announces Closing Of Public Offering

  August 18, 2017

   · 

  6 min read
• Lone Star Bio

  ViraCyte Awarded $8.99M From The Cancer Prevention And Research Institute Of Texas

  August 18, 2017

   · 

  1 min read
• Business

  Amgen And Humana Partner For Improved Health Outcomes And Efficiency

  August 18, 2017

   · 

  5 min read
• Pharm Country

  Quest Diagnostics Declares Quarterly Cash Dividend

  August 18, 2017

   · 

  1 min read
• Pharm Country

  Windtree Therapeutics Announces Initiation Of Financial Restructuring Program

  August 18, 2017

   · 

  7 min read
• Deals

  Texas’ ClearCorrect Sold in $150 Million Deal

  August 18, 2017

   · 

  2 min read
• Business

  Ligand To Receive $2 Million From Wuxi Biologics For Licensing Clinical-Stage Anti-PD-1 Antibody Discovered Using The Omniab Technology

  August 18, 2017

   · 

  4 min read
• Drug Development

  Bristol-Myers Squibb And Pfizer To Highlight Commitment To Reducing The Risk Of Stroke Caused By Non-Valvular Atrial Fibrillation (NVAF) And Treating Deep Vein Thrombosis/Pulmonary Embolism (DVT/PE) At ESC Congress 2017

  August 18, 2017

   · 

  8 min read
• Drug Development

  Ritter Pharma Announces Phase III Plans After Its End Of Phase II Meeting With FDA On RP-G28 For Lactose Intolerance

  August 18, 2017

   · 

  4 min read
• Zealand Pharma Release: Completion Of Exercise In Full Of Overallotment Option Of 15%

  August 18, 2017

   · 

  3 min read